1.Ginsenoside Rg3 improves chronic pain by activating mitochondrial function
Pei-gen ZHANG ; Hai-li ZHU ; Hui GAO
Chinese Pharmacological Bulletin 2025;41(1):94-100
Aim To explore the role and mechanism of ginsenoside Rg3 in chronic neuropathic pain.Methods The differentially expressed genes in the prefrontal cor-tex of chronic neuropathic pain were screened and ana-lyzed.The mice were randomly divided into the sham operation group,model group and drug administration group.Neuropathic pain animal model was established by chronic sciatic nerve compression injury model.Ginsenoside Rg3 was injected intraperitoneally.The changes of pain behavior in mice were recorded.HE staining,Nissl staining,Western blot and immunohisto-chemistry were used to detect nerve and mitochondrial damage in PFC brain tissue of each group.Molecular docking was used to explore the target of ginsenoside Rg3.Mito-Tracker was used to detect mitochondrial membrane potential,and ATP kit was employed to ana-lyze ATP content.Results Compared with the sham operation group,mice in the model group showed hy-peralgesia and impaired motor ability,and nerve and mitochondrial damage in PFC(P<0.05).Compared with the model group,ginsenoside Rg3 administration could increase the mechanical pain threshold,thermal foot contraction latency and stick rotation residence time of mice.At the same time,the number of inflam-matory cells,Nishi bodies and Dnm1l positive cells in PFC decreased,and the expression levels of c-Fos,IL-1β and Dnm1l protein were down-regulated(P<0.05).Molecular docking showed that ginsenoside Rg3 could bind Dnm1l.At the cellular level,ginsen-oside Rg3 administration increased mitochondrial mem-brane potential and ATP content(P<0.05).Conclu-sion Ginsenoside Rg3 can reduce the expression of inflammatory factors and mitochondria-related proteins in PFC,improve mitochondrial function,and relieve pain hypersensitivity in CCI mice.
2.The Role of Impulsivity in Cognitive Impairment in Manic Episodes of Bipolar Ⅰ Disorder
Jie LI ; Mi-liang SHI ; Gen-xiang PEI ; Xu-dong LI ; Ai-hong ZHANG
Progress in Modern Biomedicine 2025;25(15):2511-2516,2529
Objective:To observe the role of impulsivity in cognitive impairment in manic episodes of bipolar Ⅰ disorder(BPDTI)patients.Methods:180 cases of patients with BPDTI manic episodes admitted to our hospital from February 2024 to December 2024 were selected as the manic group,and another 180 cases of volunteers who were psychologically tested as normal during the same period were selected as the healthy group.The impulse Barratt-11 scale(BIS-11)and the MATRICS Consensus Cognitive Test(MCCB)were used to investigate and evaluate impulsivity and cognitive function,and correlation analysis and risk factor analysis were conducted.Results:In the BIS-11 scale,there was no statistically significant difference between the two groups in the unplanned factor(P>0.05),but there were significant differences compared between the two groups in cognitive,motor factors,and total score(P<0.05).The MCCB scores of the manic group in information processing speed,working memory,word learning,visual learning,social cognition,reasoning and problem solving,and attention vigilance were significantly lower than those of the healthy group(P<0.05).The relationship between BIS-11 total score and cognitive impulsivity factor and MCCB total score and word learning showed there were negative correlation(P<0.05);The exercise factor in the BIS-11 scale were negatively correlated with the MCCB total score and working memory factor(P<0.05);The unplanned factor in the BIS-11 scale showed there were negative correlation with the MCCB total score,word learning(P<0.05),and information processing speed.BIS-11,the number of years of education was an influencing factor for BPDTI mania(P<0.05).Conclusion:BPDTI mania patients had high impulsivity and cognitive impairment,high impulsivity and number of years of education were influencing factors for mania,high impulsivity affected cognitive function through corresponding brain regions,aggravating the condition.
3.Ginsenoside Rg3 improves chronic pain by activating mitochondrial function
Pei-gen ZHANG ; Hai-li ZHU ; Hui GAO
Chinese Pharmacological Bulletin 2025;41(1):94-100
Aim To explore the role and mechanism of ginsenoside Rg3 in chronic neuropathic pain.Methods The differentially expressed genes in the prefrontal cor-tex of chronic neuropathic pain were screened and ana-lyzed.The mice were randomly divided into the sham operation group,model group and drug administration group.Neuropathic pain animal model was established by chronic sciatic nerve compression injury model.Ginsenoside Rg3 was injected intraperitoneally.The changes of pain behavior in mice were recorded.HE staining,Nissl staining,Western blot and immunohisto-chemistry were used to detect nerve and mitochondrial damage in PFC brain tissue of each group.Molecular docking was used to explore the target of ginsenoside Rg3.Mito-Tracker was used to detect mitochondrial membrane potential,and ATP kit was employed to ana-lyze ATP content.Results Compared with the sham operation group,mice in the model group showed hy-peralgesia and impaired motor ability,and nerve and mitochondrial damage in PFC(P<0.05).Compared with the model group,ginsenoside Rg3 administration could increase the mechanical pain threshold,thermal foot contraction latency and stick rotation residence time of mice.At the same time,the number of inflam-matory cells,Nishi bodies and Dnm1l positive cells in PFC decreased,and the expression levels of c-Fos,IL-1β and Dnm1l protein were down-regulated(P<0.05).Molecular docking showed that ginsenoside Rg3 could bind Dnm1l.At the cellular level,ginsen-oside Rg3 administration increased mitochondrial mem-brane potential and ATP content(P<0.05).Conclu-sion Ginsenoside Rg3 can reduce the expression of inflammatory factors and mitochondria-related proteins in PFC,improve mitochondrial function,and relieve pain hypersensitivity in CCI mice.
4.The Role of Impulsivity in Cognitive Impairment in Manic Episodes of Bipolar Ⅰ Disorder
Jie LI ; Mi-liang SHI ; Gen-xiang PEI ; Xu-dong LI ; Ai-hong ZHANG
Progress in Modern Biomedicine 2025;25(15):2511-2516,2529
Objective:To observe the role of impulsivity in cognitive impairment in manic episodes of bipolar Ⅰ disorder(BPDTI)patients.Methods:180 cases of patients with BPDTI manic episodes admitted to our hospital from February 2024 to December 2024 were selected as the manic group,and another 180 cases of volunteers who were psychologically tested as normal during the same period were selected as the healthy group.The impulse Barratt-11 scale(BIS-11)and the MATRICS Consensus Cognitive Test(MCCB)were used to investigate and evaluate impulsivity and cognitive function,and correlation analysis and risk factor analysis were conducted.Results:In the BIS-11 scale,there was no statistically significant difference between the two groups in the unplanned factor(P>0.05),but there were significant differences compared between the two groups in cognitive,motor factors,and total score(P<0.05).The MCCB scores of the manic group in information processing speed,working memory,word learning,visual learning,social cognition,reasoning and problem solving,and attention vigilance were significantly lower than those of the healthy group(P<0.05).The relationship between BIS-11 total score and cognitive impulsivity factor and MCCB total score and word learning showed there were negative correlation(P<0.05);The exercise factor in the BIS-11 scale were negatively correlated with the MCCB total score and working memory factor(P<0.05);The unplanned factor in the BIS-11 scale showed there were negative correlation with the MCCB total score,word learning(P<0.05),and information processing speed.BIS-11,the number of years of education was an influencing factor for BPDTI mania(P<0.05).Conclusion:BPDTI mania patients had high impulsivity and cognitive impairment,high impulsivity and number of years of education were influencing factors for mania,high impulsivity affected cognitive function through corresponding brain regions,aggravating the condition.
5.Prediction of quality markers and medicinal value of sea buckthorn leaves based on network pharmacology, content determination, and activity evaluation.
Qian HE ; Kai-Lin YANG ; Xin-Yan WU ; Bo ZHANG ; Chun-Hong ZHANG ; Chun-Nian HE ; Pei-Gen XIAO
China Journal of Chinese Materia Medica 2023;48(20):5487-5497
The leaves of sea buckthorn(Hippophae rhamnoides), considered as common food raw materials, have records of medicinal use and diverse pharmacological activities, showing a potential medicinal value. However, the active substances in the sea buckthorn leaves and their mechanisms of action remain unclear. In addition, due to the extensive source and large variety variations, the quality evaluation criteria of sea buckthorn leaves remain to be developed. To solve the problems, this study predicted the main active components, core targets, key pathways, and potential pharmacological effects of sea buckthorn leaves by network pharmacology and molecular docking. Furthermore, ultra-performance liquid chromatography with diode-array detection(UPLC-DAD) was employed to determine the content of active components and establish the chemical fingerprint, on the basis of which the quality markers of sea buckthorn leaves were predicted and then verified by the enzyme activity inhibition method. The results indicated that sea buckthorn leaves had potential therapeutic effects on a variety of digestive tract diseases, metabolic diseases, tumors, and autoimmune diseases, which were consistent with the ancient records and the results of modern pharmacological studies. The core targets of sea buckthorn leaves included PTPN11, AKT1, PIK3R1, ESR1, and SRC, which were mainly involved in the PI3K-AKT, MAPK, and HIF-1 signaling pathways. In conclusion, the active components of sea buckthorn leaves are associated with the rich flavonoids and tannins, among which quercitrin, narcissoside, and ellagic acid can be used as the quality markers of sea buckthorn leaves. The findings provide a reference for the quality control and further development and utilization of sea buckthorn leaves as medicinal materials.
Hippophae/chemistry*
;
Network Pharmacology
;
Molecular Docking Simulation
;
Phosphatidylinositol 3-Kinases/metabolism*
;
Flavonoids/analysis*
;
Fruit/chemistry*
6.Research progress on chemical constituents of Schisandra chinensis and its effect on nonalcoholic fatty liver disease.
Xin-Lu MU ; Bin LI ; Yu-Cen ZOU ; Jiu-Shi LIU ; Ben-Gang ZHANG ; Pei-Gen XIAO ; Hai-Tao LIU
China Journal of Chinese Materia Medica 2023;48(4):861-878
Schisandra chinensis, a traditional Chinese medicinal herb, is rich in chemical constituents, including lignans, triterpenes, polysaccharides, and volatile oils. Clinically, it is commonly used to treat cardiovascular, cerebrovascular, liver, gastrointestinal, and respiratory diseases. Modern pharmacological studies have shown that S. chinensis extract and monomers have multiple pharmacological activities in lowering liver fat, alleviating insulin resistance, and resisting oxidative stress, and have good application prospects in alleviating nonalcoholic fatty liver disease(NAFLD). Therefore, this study reviewed the research progress on chemical constituents of S. chinensis and its effect on NAFLD in recent years to provide references for the research on S. chinensis in the treatment of NAFLD.
Non-alcoholic Fatty Liver Disease
;
Schisandra
;
Insulin Resistance
;
Lignans
7.Plant Pharmacophylogeny: Review and Future Directions.
Xue GONG ; Min YANG ; Chun-Nian HE ; Ya-Qiong BI ; Chun-Hong ZHANG ; Min-Hui LI ; Pei-Gen XIAO
Chinese journal of integrative medicine 2022;28(6):567-574
Medicinal plants have provided numerous medicinal active ingredients for thousands of years and these ingredients have been used in Chinese medicine (CM) and traditional pharmacologies worldwide. Recently, the exploitation and utilisation of medicinal plant resources has increased significantly. The results of the studies have led to the identification of many active components, such as steroidal alkaloids, saponins, terpenoids, and glycosides, in various medicinal plants with different evolutionary levels. Moreover, research on the chemical classification, molecular phylogeny, and pharmacological activity of medicinal plants is increasing in popularity. Pharmacophylogeny is an interdisciplinary topic that studies the correlation between plant phylogeny, chemical composition, and curative effects (pharmacological activity and the traditional curative effect) of medicinal plants. In addition, it provides the basic tools to enable research and development of CM resources. This literature review, based on the genetic relationship between phytogroup and species, highlights the formation process, research content, applications, and future directions of pharmacophylogeny.
Alkaloids
;
Glycosides
;
Plant Extracts/chemistry*
;
Plants, Medicinal/chemistry*
;
Saponins
;
Terpenes
8.Association of single nucleotide polymorphisms of PTPRD and restless legs syndrome:a Meta-analysis
Journal of Apoplexy and Nervous Diseases 2022;39(3):206-209
The aim of the study is to investigate the association of rs1975197 and rs4626664 of PTPRD and restless legs syndrome (RLS).Methods We retrieved 4 studies on rs1975197 and 5 studies of rs4626664 and extracted basic information of each study following inclusion and exclusion criteria. Meta-analysis was used to analyze odds ratio(OR)and 95% confidence intervals(CI).Forest plots were used to assess heterogeneity visually.If heterogeneity existed,subgroup analysis would be used. Funnel plots was used to assess publication bias visually.Results As for rs1975197,T allele could increase the risk of RLS in Caucasian(OR=1.43,95%CI 1.13~1.80).However,there were no statistically significant of rs4626664 observed in neither overall analysis nor subgroup analysis.Conclusion T allele of rs1975197 of PTPRD increases the risk of RLS in Caucasian using Meta-Analysis,suggesting a race specificity of PTPRD with RLS. More and larger case-control studies including different races need to be launched for investigating the association of PTPRD with RLS.
9.A preliminary pharmacophylogenetic study of Solanaceae medicinal plants containing tropane alkaloids.
Er-Huan ZANG ; Qin-Yu LI ; Jin-Fan XU ; Yi ZHANG ; Lin-Lin JIANG ; Xue LI ; Ming-Xu ZHANG ; Yu-Chao LIU ; Qing-Jiang WU ; Zhao-Hua LIU ; Min-Hui LI ; Pei-Gen XIAO
China Journal of Chinese Materia Medica 2021;46(17):4344-4359
The Solanaceae plants distributed in China belong to 105 species and 35 varietas of 24 genera. Some medicinal plants of Solanaceae are rich in tropane alkaloids(TAs), which have significant pharmacological activities. In this paper, the geographical distribution, chemical components, traditional therapeutic effect, pharmacological activities, and biosynthetic pathways of TAs in Solanaceous plants were summarized. Besides, the phylogeny of medicinal plants belonging to Solanaceae was visualized by network diagram. Fourteen genera of Solanaceae plants in China contain TAs and have medical records. TAs mainly exist in Datura, Anisodus, Atropa, Physochlaina, and Hyoscyamus. The TAs-containing species were mainly concentrated in Southwest China, and the content of TAs was closely related to plant distribution area and altitude. The Solanaceae plants containing TAs mainly have antispasmodic, analgesic, antiasthmatic, and antitussive effects. Modern pharmacological studies have proved the central sedative, pupil dilating, glandular secretion-inhibiting, and anti-asthma activities of TAs. These pharmacological activities provide a reasonable explanation for the traditional therapeutic efficacy of tropane drugs. In this paper, the geographical distribution, chemical components, traditional therapeutic effect, and modern pharmacological activities of TAs-containing species in Solanaceae were analyzed for the first time. Based on these data, the genetic relationship of TAs-containing Solanaceae species was preliminarily discussed, which provided a scientific basis for the basic research on TAs-containing solanaceous species and was of great significance for the development of natural medicinal plant resources containing TAs.
Biosynthetic Pathways
;
Phylogeny
;
Plants, Medicinal
;
Solanaceae/genetics*
;
Tropanes
10.Effect of Yiqi Yangyin Prescription on Lipid Metabolism in Rats with Type 2 Diabetes
Zhen REN ; Pei-fang DAI ; Yue LIU ; Jing ZHANG ; Xin MU ; Gen-li LIU
Chinese Journal of Experimental Traditional Medical Formulae 2021;27(7):57-65
Objective:To observe the effect of Yiqi Yangyin prescription on lipid metabolism in type 2 diabetes rat model induced by high fat diet combined with intraperitoneal injection of streptozocin (STZ), and explore its mechanism in regulation of lipid metabolism. Method:The rats were fed with high-fat diet for 4 weeks, and intraperitoneal injection of STZ was provided to establish diabetes model. The diabetic rats were randomly divided into model group, Yiqi Yangyin prescription high dose group, medium dose group and low dose group (9.00, 4.50, 2.25 g·kg-1) and metformin group (0.20 g·kg-1). Another blank control group was set up. The high, medium and low dose groups were given with different oral doses of Yiqi Yangyin prescription granules, metformin was given in metformin group, the model group and the blank group received the same volume of normal saline. Intragastric administration was given for three weeks, and then the weight and blood glucose were measured. Automatic biochemical analyzer was used to detect triglyceride (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and content of total protein (TP). Hematoxylin-eosin (HE) staining was used to observe the pathological changes of liver tissues in each group. Periodic acid-schiff stain (PAS) staining was used to observe the pathological changes of liver glycogen. The lipid changes of liver tissues were observed by oil red O staining. The expression of adenosine monophosphate activated protein kinase (AMPK)/ sterol regulatory element binding protein 1c (SREBP1c)/acetyl-coenzyme A carboxylase (ACC1)/peroxisome proliferator activated re-ceptor


Result Analysis
Print
Save
E-mail